Mode
Text Size
Log in / Sign up
N/A Completed N=65 Diagnostic

Continuous Non-Invasive Measurement of Hemoglobin During Parturition

Source: ClinicalTrials.gov NCT03150043 ↗
Enrolled (actual)
65
Serious AEs
0.0%
Results posted
Feb 2021
Primary outcomePrimary: Pearson Correlation Coefficient for Hemoglobin Measurements — 0.6 Correlation Coeficient

Summary

A non-invasive hemoglobin monitor will be used during cesarean delivery and the values obtained will be compared to values obtained from traditional blood draw.

Outcome Measures

OutcomeResultp-value
PRIMARY
Pearson Correlation Coefficient for Hemoglobin Measurements
0.6
SECONDARY
Number of Participants Who Required Blood Transfusion
65

Eligibility Criteria

Inclusion Criteria

  • Pregnant women undergoing primary cesarean delivery after failed induction of labor, or repeat cesarean delivery after failed TOLAC (trial of labor after cesarean)
  • Pregnant women between the ages of 18-50

Exclusion Criteria

  • Patient who are not pregnant
  • Patients unwilling or unable to provide consent
  • Patients under the age of 18
  • Patients who are incarcerated
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03150043). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search